These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7474121)

  • 1. Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.
    Billstrom MA; Britt WJ
    J Virol; 1995 Nov; 69(11):7015-22. PubMed ID: 7474121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).
    Britt WJ; Vugler LG
    J Virol; 1992 Nov; 66(11):6747-54. PubMed ID: 1328688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.
    Yamashita Y; Shimokata K; Mizuno S; Daikoku T; Tsurumi T; Nishiyama Y
    J Virol; 1996 Apr; 70(4):2237-46. PubMed ID: 8642648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding, unfolding, and refolding of the vesicular stomatitis virus glycoprotein.
    Mathieu ME; Grigera PR; Helenius A; Wagner RR
    Biochemistry; 1996 Apr; 35(13):4084-93. PubMed ID: 8672443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide bond configuration of human cytomegalovirus glycoprotein B.
    Lopper M; Compton T
    J Virol; 2002 Jun; 76(12):6073-82. PubMed ID: 12021340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles.
    Laquerre S; Anderson DB; Argnani R; Glorioso JC
    J Virol; 1998 Jun; 72(6):4940-9. PubMed ID: 9573262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.
    Kari B; Gehrz R
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():255-64. PubMed ID: 8381465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.
    Loh LC
    Virology; 1991 Jan; 180(1):239-50. PubMed ID: 1845824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55).
    Eickmann M; Lange R; Ohlin M; Reschke M; Radsak K
    Arch Virol; 1998; 143(10):1865-80. PubMed ID: 9856077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and characterization of a soluble form of human cytomegalovirus glycoprotein B.
    Carlson C; Britt WJ; Compton T
    Virology; 1997 Dec; 239(1):198-205. PubMed ID: 9426459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of intermolecular disulfide bonds in P22 tailspike protein intermediates in the presence of SDS.
    Kim J; Robinson AS
    Protein Sci; 2006 Jul; 15(7):1791-3. PubMed ID: 16751612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of intermediates involved in the folding pathway for recombinant human macrophage colony-stimulating factor (M-CSF): evidence for two distinct folding pathways.
    Wilkins JA; Cone J; Randhawa ZI; Wood D; Warren MK; Witkowska HE
    Protein Sci; 1993 Feb; 2(2):244-54. PubMed ID: 8443602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding and oxidation of the antibody domain C(H)3.
    Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
    J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.
    Singh J; Compton T
    J Virol; 2000 Feb; 74(3):1383-92. PubMed ID: 10627549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.
    Dubuisson J; Rice CM
    J Virol; 1996 Feb; 70(2):778-86. PubMed ID: 8551615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
    Britt WJ; Jarvis MA; Drummond DD; Mach M
    J Virol; 2005 Apr; 79(7):4066-79. PubMed ID: 15767408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
    Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of intermediates involved in the in vitro folding pathways of recombinant human macrophage colony stimulating factor beta by sulfhydryl group trapping and hydrogen/deuterium pulsed labeling.
    Zhang YH; Yan X; Maier CS; Schimerlik MI; Deinzer ML
    Biochemistry; 2002 Dec; 41(52):15495-504. PubMed ID: 12501178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
    Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
    J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotranslational folding and calnexin binding during glycoprotein synthesis.
    Chen W; Helenius J; Braakman I; Helenius A
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6229-33. PubMed ID: 7541532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.